PKM2 knockdown by siRNA in glioma cells has been demonstrated to induce cell apoptosis and inhibit cell growth, cellular invasion, metabolic activity, ATP levels and glutathione levels (33). This evidence concerns the gene PKM and central nervous system cancer.